EC Paediatrics

Case Series Volume 14 Issue 6 - 2025

Rare But Real: A Decade of Pediatric Bladder Tumors in a Single-Center Experience

Ester Ricci1*, Elisa Magrini1, Marilù Garo2, Mohamed Vincenti1, Bernardino Melissa1, Niccolò Nardi1 and Marco Prestipino1

1Pediatric Surgery Unit, Azienda Ospedaliera di Perugia “Santa Maria della Misericordia”, Perugia, Italy
2Independent Research, Rome, Italy

*Corresponding Author: Ester Ricci, Department of Pediatric Surgery, Santa Maria della Misericordia Hospital, Perugia, Italy.
Received: May 02, 2025; Published: May 21, 2025



Introduction: Pediatric bladder tumors are rare and biologically distinct from their adult counterparts, exhibiting notable differences in histology, clinical behavior, and prognosis. Due to their low incidence and heterogeneity, standardized diagnostic and surveillance protocols for children are lacking. This study aims to present a decade-long, single-center experience, providing key insights into the diagnosis, treatment, and follow-up of pediatric bladder tumors, with the goal of contributing to the development of pediatric-specific management strategies.

Observations: Between 2013 and 2023, seven pediatric patients (ages 3 - 15 years) were diagnosed with bladder tumors at our institution. Histopathological diagnoses included papillary urothelial neoplasms of low malignant potential, low-grade urothelial carcinoma, papilloma, fibroepithelial polyp, inflammatory myofibroblastic tumor, hemangioma, and rhabdomyosarcoma. Clinical presentations ranged from incidental imaging findings to gross hematuria and urinary retention. Management strategies were individualized based on tumor type, location, and severity, including transurethral resection, laser ablation, partial cystectomy, or multimodal oncologic therapy. No recurrences were observed during a median follow-up of 3.5 years. Diagnostic imaging, cystoscopy, and histopathological evaluation were essential for accurate diagnosis, and treatment prioritized bladder preservation when feasible.

Conclusion and Relevance: Pediatric bladder tumors typically follow an indolent course and respond well to conservative surgical approaches, with excellent long-term outcomes. This experience underscores the need for pediatric-specific diagnostic pathways and follow-up protocols that minimize unnecessary invasiveness while ensuring oncological safety. The adoption of histology-adapted surveillance strategies could significantly enhance patient care by preventing overtreatment of low-risk lesions and ensuring vigilant monitoring of high-risk tumors.

 Keywords: Pediatric Bladder Tumors; Papillary Urothelial Neoplasms of Low Malignant Potential (PUNLMP); Rhabdomyosarcomas (RMS)

  1. Lopes RI and Lorenzo AJ. “Contemporary management of urothelial carcinoma in children and adolescents”. Current Urology Reports 11 (2020): 45.
  2. Shaheen A., et al. “Urothelial bladder cancer in the paediatric population: A review of the literature”. Urologia Internationalis 4 (2010): 359-364.
  3. Wong-You-Cheong JJ., et al. “From the archives of the AFIP: Neoplasms of the urinary bladder: Radiologic-pathologic correlation”. Radiographics2 (2006): 553-580.
  4. Marinoni G., et al. “Urothelial bladder carcinoma in adolescence: A case report and literature review”. La Pediatria Medica e Chirurgica 4 (2018): 211.
  5. Alanee S and Shukla AR. “Bladder cancer in children and adolescents”. Urologic Oncology 5 (2010): 519-523.
  6. Cheng L., et al. “Tumor grade and stage as prognostic variables in bladder carcinoma”. American Journal of Clinical Pathology 3 (1999): 398-405.
  7. Abdullaev FK, et al. “Bladder hemangiomas in children: A rare cause of hematuria”. Urology3 (2011): 691-694.
  8. Mor Y., et al. “Bladder hemangioma in children”. Journal of Urology 3 (1997): 1388.
  9. Saltzman AF and Cost NG. “Pediatric genitourinary rhabdomyosarcoma: Epidemiology, pathogenesis, and clinical features”. Urologic Clinics of North America 4 (2018): 717-723.
  10. Crist WM., et al. “The Third Intergroup Rhabdomyosarcoma Study”. Journal of Clinical Oncology 12 (2001): 3091-3101.
  11. Lerena J., et al. “Pediatric bladder tumors: Diagnostic and therapeutic aspects”. Journal of Urology 5 (2006): 1798-1801.
  12. Paner GP., et al. “Urothelial neoplasms in children and young adults: A review”. Archives of Pathology and Laboratory Medicine 3 (2011): 371-377.
  13. Castagnetti M., et al. “Conservative management of bladder tumors in children”. Journal of Pediatric Urology 5 (2015): 239.e1-239.e6.
  14. Rousseau B., et al. “Inflammatory myofibroblastic tumor of the bladder: ALK-positive case and literature review”. Canadian Urological Association Journal 4 (2020): E170-E174.
  15. Berrettini A., et al. “Pediatric bladder tumors: A report of 21 cases and review of the literature”. Pediatric Surgery International 5 (2015): 437-441.
  16. Shelmerdine SC., et al. “Diagnostic imaging of pediatric hematuria”. Clinical Radiology 12 (2017): 1033-1045.
  17. Wu HY and Snyder HM. “Laser treatment of bladder lesions in children”. Journal of Urology 4.2 (2004): 1666-1669.
  18. Caione P., et al. “Long-term follow-up of non-invasive bladder tumors in children”. Journal of Pediatric Urology 5 (2016): 275.e1-275.e5.
  19. Di Carlo HN., et al. “Urothelial carcinoma in pediatric and adolescent patients: A review”. Journal of Pediatric Urology 3 (2014): e1-e5.

Ester Ricci., et al. "Rare But Real: A Decade of Pediatric Bladder Tumors in a Single-Center Experience". EC Paediatrics 14.6 (2025): 01-09.